title: NKp44L: A new tool for fighting cancer.
abstract: We have recently identified that the ligand of natural cytotoxicity triggering receptor 2 (NCR2, best known as NKp44) is expressed on a large panel of malignant cells. This ligand provides a new tool to investigate how stressed cells are recognized and eliminated by natural killer (NK) cells, and to develop novel immunotherapeutic paradigms against cancer.
authors.affiliation: Sorbonne Université; UPMC, Univ Paris 06; CR7; CIMI-Paris; Paris, France ; INSERM, U1135; CIMI-Paris; Paris, France ; CNRS, ERL8255; CIMI-Paris; Paris, France.
authors.forename: Vincent
authors.initials: V
authors.lastname: Vieillard
authors.affiliation: Sorbonne Université; UPMC, Univ Paris 06; CR7; CIMI-Paris; Paris, France ; INSERM, U1135; CIMI-Paris; Paris, France ; CNRS, ERL8255; CIMI-Paris; Paris, France.
authors.forename: Florence
authors.initials: F
authors.lastname: Baychelier
authors.affiliation: Sorbonne Université; UPMC, Univ Paris 06; CR7; CIMI-Paris; Paris, France ; INSERM, U1135; CIMI-Paris; Paris, France ; CNRS, ERL8255; CIMI-Paris; Paris, France.
authors.forename: Patrice
authors.initials: P
authors.lastname: Debré
keywords: MLL5; NKp44; NKp44L; immunotherapy; natural cytotoxicity receptors; natural killer cells; tumor cells